Finished
Vascular Resection in Robotic Pancreaticoduodenectomy for Pancreatic Cancer
NCT07871045 · Taipei Veterans General Hospital, Taiwan · Updated 13 Oct 2026
- What is being tested
- vascular resection
- For
- Vascular Resection; Pancreatic Cancer; Robotic Pancreaticoduodenectomy
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages Not stated. About 239 people. The full rules are on the registry page.
- Where
- Taiwan
- When
- Starts or started 1 July 2025, ends 31 Dec 2025. Registered 13 Oct 2026.
- Results
- None posted yet.
In the researchers' words
Data for this propensity score-matched (PSM) comparative study were obtained from a prospectively maintained database comprising 679 cases of robotic pancreaticoduodenectomy (RPD). This study aimed to evaluate the feasibility and justification of vascular resection (VR) in RPD for pancreatic cancer. The primary study endpoint was to compare the surgical outcomes between patients undergoing VR (+) and VR (-) in RPD using PSM to minimize selection bias and allow for balanced comparisons. The secondary study endpoint was to assess the impact of VR on oncological outcomes and overall survival in patients with pancreatic cancer undergoing RPD.
Sites
- General Surgery, Taipei Veterans General HospitalTaipei, Other, Taiwan